Significance of epithelial growth factor in the epithelial-mesenchymal transition of human gallbladder cancer cells

Cancer Sci. 2012 Jun;103(6):1165-71. doi: 10.1111/j.1349-7006.2012.02264.x. Epub 2012 Apr 3.

Abstract

Five gallbladder cancer (GBC) cell lines were examined for morphological changes in collagen gel culture. GBh3 and HUCCT-1 cells formed tubules in response to treatment with epithelial growth factor (EGF) and hepatocyte growth factor (HGF), and showed high levels of expression of E-cadherin (ECD), and low levels of SNAIL, vimentin, transforming growth factor (TGF)-β, and nucleostemin (NS). In contrast, the GBd15 and FU-GBC-1 cell lines treated with EGF and HGF showed a scattering phenotype, and expressed low levels of ECD and high levels of SNAIL, vimentin, TGF-β, and NS. All cell lines expressed the EGF receptor, c-Met, EGF, and TGF-α, but not HGF. Transforming growth factor-β was upregulated by EGF. Knockdown of the EGF receptor abrogated both tubule formation and scattering, whereas KD of TGF-β abrogated only scattering. Knockdown of EGF induced nuclear translocation of β-catenin and Wnt-related NS induction in the scattering cell lines, but not in the tubule-forming cell lines, whereas KD of glycogen synthase kinase-3β in the tubule-forming cell lines resulted in the nuclear translocation of β-catenin and Wnt-related NS induction in response to EGF treatment. These results suggest that EGF enhances epithelial-mesenchymal transformation and acquisition of stemness in GBC cells with a scattering phenotype through the activity of β-catenin. Repression of ECD in scattering GBC cells induced the release of β-catenin from the cell adhesion complexes along the plasma membrane and its translocation to the nucleus to activate Wnt signaling, which upregulated NS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Cadherins / biosynthesis
  • Cell Line, Tumor
  • Cell Proliferation
  • Epidermal Growth Factor / pharmacology
  • Epidermal Growth Factor / physiology*
  • Epithelial-Mesenchymal Transition*
  • ErbB Receptors / biosynthesis
  • ErbB Receptors / genetics
  • GTP-Binding Proteins / biosynthesis
  • Gallbladder Neoplasms / metabolism*
  • Gallbladder Neoplasms / pathology*
  • Glycogen Synthase Kinase 3 / genetics
  • Glycogen Synthase Kinase 3 beta
  • Hepatocyte Growth Factor / pharmacology
  • Hepatocyte Growth Factor / physiology*
  • Humans
  • Nuclear Proteins / biosynthesis
  • Proto-Oncogene Proteins c-met / biosynthesis
  • RNA Interference
  • RNA, Small Interfering
  • Recombinant Proteins / pharmacology
  • Snail Family Transcription Factors
  • Transcription Factors / biosynthesis
  • Transforming Growth Factor alpha / biosynthesis
  • Transforming Growth Factor beta / biosynthesis
  • Transforming Growth Factor beta / genetics
  • Vimentin / biosynthesis
  • Wnt Signaling Pathway
  • beta Catenin / metabolism

Substances

  • Cadherins
  • GNL3 protein, human
  • HGF protein, human
  • Nuclear Proteins
  • RNA, Small Interfering
  • Recombinant Proteins
  • Snail Family Transcription Factors
  • Transcription Factors
  • Transforming Growth Factor alpha
  • Transforming Growth Factor beta
  • Vimentin
  • beta Catenin
  • Epidermal Growth Factor
  • Hepatocyte Growth Factor
  • ErbB Receptors
  • Proto-Oncogene Proteins c-met
  • GSK3B protein, human
  • Glycogen Synthase Kinase 3 beta
  • Glycogen Synthase Kinase 3
  • GTP-Binding Proteins